Digital PCR and Real-time PCR (qPCR) Market - Leading Market Players Future Growth
Market growth factors
Factors such as the growth
in the geriatric population, rising incidence of infectious diseases and
genetic disorders, technological advancements in the field of PCR, and
increasing investments and availability of funds for PCR-based research are
driving the growth of the global dPCR and qPCR market.
What experts says
about the growth of this market?
According to latest
research Digital
PCR and qPCR Market is expected to reach USD 5.31 Billion by 2022, growing
at a CAGR of 8.9% during the forecast period. The report dPCR and
qPCR market during the forecast period of 2017 to 2022.
(Source: MarketsandMarkets™)
Key players
The key players in the
digital PCR and real-time PCR (qPCR) market focused on various strategies such
as product launches and approvals; partnerships, collaborations and agreements;
mergers and acquisitions; and expansions to enhance their presence in the
global market. Product approvals, launches, and enhancements were the key
strategies adopted by a majority of industry players to achieve growth in the dPCR
and qPCR market. Several prominent dPCR and qPCR product manufacturers such as
Thermo Fisher Scientific Inc., Bio-Rad Laboratories, F. Hoffman-la Roche Ltd.,
QIAGEN N.V., and Takara Bio, Inc. are focused on the development and
commercialization of innovative dPCR and qPCR instruments and qPCR reagents to
keep pace with the ongoing industry trends and to maintain their revenue base.
As of 2016, Thermo Fisher
Scientific Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), F. Hoffmann-La Roche
Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Takara Bio, Inc. (U.S.), Agilent
Technologies Inc. (U.S.), bioMérieux S.A. (France), Fluidigm Corporation
(U.S.), Danaher Corporation (U.S.), and Abbott Laboratories (U.S.) were some of
the key players operating in the global dPCR and qPCR market.
Geographic Overview
North America is expected
to account for the largest share of the global dPCR and qPCR market in 2017,
followed by Europe. The strong position of North America in this market can be
attributed to factors such as increase in public and private funding and
growing number of research grants to support gene-based research (such as qPCR
and dPCR). However, Asia-Pacific (comprising China, India, Japan, and RoAPAC)
is projected to be the fastest-growing region in the qPCR and dPCR market owing
to increasing focus of global life sciences market players on this region,
burgeoning efforts to increase awareness related to gene-based disease
diagnosis and treatment, growing public and private support to develop novel
qPCR and dPCR technologies, growth in the Indian genomics market, and growing
cancer research in Japan. Due to the significant growth opportunities offered
by emerging countries, a number of players operating in the market are focusing
on expanding their product distribution networks across emerging countries.
Contact:
Mr. Shelly Singh
MarketsandMarkets™
INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
newsletter@marketsandmarkets.com
Comments
Post a Comment